| Microbial metabolite sensor GPR43 controls severity of experimental GVHD H Fujiwara, MD Docampo, M Riwes, D Peltier, T Toubai, I Henig, SJ Wu, ... Nature communications 9 (1), 3674, 2018 | 121 | 2018 |
| α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease JM Magenau, SC Goldstein, D Peltier, RJ Soiffer, T Braun, A Pawarode, ... Blood, The Journal of the American Society of Hematology 131 (12), 1372-1379, 2018 | 99 | 2018 |
| Infectious risk after allogeneic hematopoietic cell transplantation complicated by acute graft-versus-host disease HK Miller, TM Braun, T Stillwell, AC Harris, S Choi, J Connelly, D Couriel, ... Biology of Blood and Marrow Transplantation 23 (3), 522-528, 2017 | 68 | 2017 |
| Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT SW Choi, T Braun, I Henig, E Gatza, J Magenau, B Parkin, A Pawarode, ... Blood, The Journal of the American Society of Hematology 130 (15), 1760-1767, 2017 | 61 | 2017 |
| FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML Y Song, J Magenau, Y Li, T Braun, L Chang, D Bixby, DA Hanauer, ... Bone marrow transplantation 51 (4), 511-520, 2016 | 48 | 2016 |
| Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition T Toubai, H Fujiwara, C Rossi, M Riwes, H Tamaki, C Zajac, C Liu, ... Nature microbiology 4 (5), 800-812, 2019 | 45 | 2019 |
| Microbial metabolites and graft versus host disease M Riwes, P Reddy American journal of transplantation 18 (1), 23-29, 2018 | 43 | 2018 |
| Short chain fatty acids: postbiotics/metabolites and graft versus host disease colitis M Riwes, P Reddy Seminars in hematology 57 (1), 1-6, 2020 | 34 | 2020 |
| Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies MM Riwes, JR Wingard Expert review of hematology 5 (6), 661-669, 2012 | 34 | 2012 |
| A phase 2 study of pembrolizumab during lymphodepletion after autologous hematopoietic cell transplantation for multiple myeloma A D'Souza, P Hari, M Pasquini, T Braun, B Johnson, S Lundy, D Couriel, ... Biology of Blood and Marrow Transplantation 25 (8), 1492-1497, 2019 | 31 | 2019 |
| Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: data from a prospective series of patients AA Mangaonkar, KJ Langer, TL Lasho, C Finke, MR Litzow, WJ Hogan, ... John Wiley & Sons, Inc., 2023 | 27 | 2023 |
| Analytic morphomics: a novel CT imaging approach to quantify adipose tissue and muscle composition in allogeneic hematopoietic cell transplantation K Chughtai, Y Song, P Zhang, B Derstine, E Gatza, J Friedman, L Hully, ... Bone Marrow Transplantation 51 (3), 446-450, 2016 | 27 | 2016 |
| IAPs protect host target tissues from graft-versus-host disease in mice T Toubai, C Rossi, K Oravecz-Wilson, C Liu, C Zajac, SRJ Wu, Y Sun, ... Blood Advances 1 (19), 1517-1532, 2017 | 24 | 2017 |
| Murine models of steroid refractory graft-versus-host disease T Toubai, C Rossi, I Tawara, C Liu, C Zajac, K Oravecz-Wilson, D Peltier, ... Scientific reports 8 (1), 12475, 2018 | 17 | 2018 |
| Type 1 interferon to prevent leukemia relapse after allogeneic transplantation JM Magenau, D Peltier, M Riwes, A Pawarode, B Parkin, T Braun, ... Blood advances 5 (23), 5047-5056, 2021 | 16 | 2021 |
| Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission JM Magenau, T Braun, P Reddy, B Parkin, A Pawarode, S Mineishi, ... Annals of Hematology 94, 1033-1041, 2015 | 14 | 2015 |
| Phase 2 study of pembrolizumab during lymphodepleted state after autologous hematopoietic cell transplantation in multiple myeloma patients A Pawarode, A D'Souza, MC Pasquini, B Johnson, T Braun, B Dhakal, ... Blood 130, 339, 2017 | 9 | 2017 |
| Cardiovascular events after hematopoietic stem cell transplant: incidence and risk factors A Vasbinder, CW Hoeger, T Catalan, E Anderson, C Chu, M Kotzin, J Xie, ... Cardio Oncology 5 (6), 821-832, 2023 | 8 | 2023 |
| Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic … MM Riwes, H Leather, D Neal, C Bennett, M Sugrue, C Cline, J Stokes, ... Bone Marrow Transplantation 51 (9), 1228-1232, 2016 | 8 | 2016 |
| The effect of azithromycin on relapse in patients with moderate-severe chronic graft versus host disease (CGVHD) M Shamoun, T Braun, JM Magenau, SW Choi, P Reddy, A Pawarode, ... Biology of Blood and Marrow Transplantation 25 (3), S26-S27, 2019 | 7 | 2019 |
